Avanos Medical Expands Critical Care Solutions with Nexus Medical Acquisition

Avanos Medical Acquires Nexus Medical

On September 15, 2025, Avanos Medical, Inc. (NYSE: AVNS), a key player in the medical technology sector, announced an important acquisition that will enhance its services in critical care environments. The company has acquired Nexus Medical, LLC, a private medical device firm renowned for its innovative TKO® anti-reflux needleless connector technology. This acquisition is part of Avanos' ongoing strategy to improve the delivery of nutrition and medication, particularly in high-acuity settings such as Neonatal and Pediatric Intensive Care Units (NICUs and PICUs).

Why Nexus Medical?

Nexus Medical has established itself as a pioneering force in developing solutions that mitigate the risks associated with IV-based nutrition and medication delivery. Their TKO® anti-reflux technology is specifically designed to prevent blood reflux, which can lead to catheter occlusions and increase infection risks during treatment. By integrating Nexus’s cutting-edge solutions into its Specialty Nutrition Systems business, Avanos aims to solidify its commitment to providing safe and efficient therapy for vulnerable patient populations.

According to Dave Pacitti, CEO of Avanos, "This acquisition clearly extends our strategy to deliver smarter, safer solutions across the critical care spectrum." He emphasized that adding Nexus’s offerings will enable them to invest further in innovation that enhances care and improves patient outcomes in critical settings, where reliable and effective treatment is paramount.

The TKO® Technology

The TKO® needleless connector features a unique, pressure-activated tri-seal silicone valve. This design minimizes the risk of blood reflux, a common issue faced by healthcare professionals when administering IV treatments. This can significantly decrease therapy delays and enhance patient safety by preventing infections and potential catheter complications. As healthcare providers seek to maintain the highest standards of care, the adoption of technologies like TKO® becomes increasingly critical.

Kerr Holbrook, Avanos' Chief Commercial Officer, noted, "Nexus TKO® naturally fits into our Specialty Nutrition Systems business and is expected to provide immediate value in NICU and PICU care. It's a practical, trusted solution that can greatly assist clinicians." This acquisition aligns with a broader trend within the healthcare industry to innovate and improve standards of care, especially for those patients requiring intricate freedom when it comes to nutrition and medication administration.

Financial Implications

The acquisition has been financed through available cash, with Avanos expecting it to be immediately accretive to both revenue growth and earnings per share. This financial strategy emphasizes Avanos' confidence in the added value Nexus Medical will bring to its portfolio and client base.

About Avanos Medical

Founded and headquartered in Alpharetta, Georgia, Avanos Medical specializes in the development and marketing of medical device solutions aimed at enhancing patient care. Their focus spans crucial areas of healthcare delivery, including improving nutritional support for patients and offering alternatives to opioid pain management. With a commitment to innovation and customer needs, Avanos holds strong market positions across multiple product categories, catering to the urgent needs of healthcare professionals globally.

Overview of Nexus Medical

Established in 2001, Nexus Medical has carved out a niche in the medical device industry by addressing the challenges posed by traditional needleless connectors. Their TKO® technology is recognized for its effectiveness and reliability, significantly reducing complications in IV therapy. As the market leader in this specialty, their products are backed by robust clinical research, underscoring their commitment to advancing healthcare safety.

For more information on Avanos Medical and its comprehensive product offerings, visit their official website or follow them on social media platforms such as X (formerly Twitter), LinkedIn, and Facebook.

The acquisition of Nexus Medical represents a significant milestone for Avanos, further fortifying their position in the healthcare landscape and reaffirming their dedication to quality patient care.